Skip to main content
MED
NYSE Manufacturing

Chief Legal Officer Resigns Amidst Ongoing Executive Changes

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
7
Price
$13.19
Mkt Cap
$139.323M
52W Low
$9.22
52W High
$15.46
52W Position info
43% above low
Off High info
15% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

MED sits 43% above its 52-week low of $9.22 on elevated volume (1.9× avg).

Summary

Medifast's Chief Legal Officer and Corporate Secretary, Jason L. Groves, has resigned, marking another executive departure during a period of significant leadership transition and financial challenges.


Key Events · Executive and Board Changes · MED

  • Chief Legal Officer Resigns

    Jason L. Groves, Chief Legal Officer & Corporate Secretary, resigned from Medifast, Inc. effective May 29, 2026.

  • Amicable Departure Stated

    The company stated that Mr. Groves' departure was not due to any disagreement with the company's operations, policies, or practices.

  • Severance Package

    Mr. Groves will receive a one-time lump sum cash severance payment of $35,648.42, equal to one month of his annual base salary.

  • Search for Replacement Initiated

    Medifast has commenced a search for a permanent replacement for the Chief Legal Officer role.


Analysis · MED · Manufacturing

The resignation of a C-suite executive, even if stated as amicable and not due to disagreements, adds to the ongoing executive turnover at Medifast. This follows closely after the finalization of a new CEO appointment on May 26, 2026, and comes amidst a challenging financial period for the company, as evidenced by its recent Q1 2026 earnings report. While the severance package is small, the departure of a key legal officer during a time of activist investor involvement could introduce further uncertainty regarding corporate governance and stability.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MED was trading at $13.19 on NYSE in the Manufacturing sector, with a market capitalization of approximately $139.3M. The 52-week trading range was $9.22 to $15.46. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MED - Latest Insights

MED
Nov 20, 2026, 3:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $11.72
Real-time Price: $11.75 info
Change: +$0.030 (+0.26%) info
Market Cap: $131.395M info
MED
Nov 20, 2026, 2:44 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $11.48
Real-time Price: $11.75 info
Change: +$0.275 (+2%) info
Market Cap: $131.395M info
MED
Oct 26, 2026, 8:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.87
Real-time Price: $11.75 info
Change: -$0.120 (-1%) info
Market Cap: $131.395M info
MED
Aug 28, 2026, 12:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.95
Real-time Price: $11.75 info
Change: -$0.200 (-2%) info
Market Cap: $131.395M info
MED
Aug 21, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $11.95
Real-time Price: $11.75 info
Change: -$0.200 (-2%) info
Market Cap: $131.395M info